Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening

J Pediatr. 2004 May;144(5):632-6. doi: 10.1016/j.jpeds.2004.01.035.

Abstract

Objective: To test the possibility of detecting tissue transglutaminase autoantibodies (tTG-Abs) in saliva with a novel sensitive fluid-phase radioimmunoassay (RIA).

Study design: Paired saliva and serum samples from 39 patients with celiac disease (CD), at the first biopsy (Group 1: 28 females, mean age 11.5 +/- 11.1 years); 32 controls with a normal duodenal mucosa (Group 2: 18 females, mean age 8.1 +/- 3.6 years); and 32 healthy volunteers (Group 3: 21 females, mean age 31.7 +/- 9.8 years) were studied for tTG-Ab presence. Limit of positivity for salivary assay was calculated according to the 99th percentiles of Group 2 control children and was expressed as an autoantibody (Ab) index.

Results: Salivary tTG-Abs were found in 97.4% of the patients with CD and in 100% of the corresponding serum samples. All Group 3 subjects were negative with both saliva and serum assays. A correlation between saliva and serum tTG-Ab titers was found (r=0.826, P=.0014).

Conclusions: This study demonstrates that it is possible to detect salivary tTG-Abs in CD with a non-invasive, simple to perform, reproducible and sensitive method.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies / metabolism*
  • Case-Control Studies
  • Celiac Disease / diagnosis*
  • Celiac Disease / immunology
  • Celiac Disease / prevention & control
  • Child
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Mass Screening / methods
  • Radioimmunoassay / methods
  • Reproducibility of Results
  • Saliva / metabolism
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Transglutaminases / immunology*

Substances

  • Autoantibodies
  • Transglutaminases